Hydroxyurea (Hydroxycarbamide), Ribonucleotide reductase inhibitor (ab142613)

Overview

  • Product name

    Hydroxyurea (Hydroxycarbamide), Ribonucleotide reductase inhibitor
  • Description

    Ribonucleotide reductase inhibitor
  • Biological description

    Ribonucleotide reductase inhibitor. Various biological activities including anticancer and antiretroviral properties. Induces apoptosis in vitro.
  • Purity

    > 98%
  • CAS Number

    127-07-1
  • Chemical structure

    Chemical Structure

Properties

References

This product has been referenced in:

  • Lee HL  et al. Effects of ribavirin and hydroxyurea on oral infection of Aedes aegypti (L.) with dengue virus. Southeast Asian J Trop Med Public Health 43:1358-64 (2012). Read more (PubMed: 23413698) »
  • Rassnick KM  et al. Phase II open-label study of single-agent hydroxyurea for treatment of mast cell tumours in dogs. Vet Comp Oncol 8:103-11 (2010). Read more (PubMed: 20579323) »
  • Hendricks SP & Mathews CK Differential effects of hydroxyurea upon deoxyribonucleoside triphosphate pools, analyzed with vaccinia virus ribonucleotide reductase. J Biol Chem 273:29519-23 (1998). Read more (PubMed: 9792659) »

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab142613.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES, NOT FOR USE IN HUMANS"
For licensing inquiries, please contact partnerships@abcam.com

Sign up